According to the Rome IV criteria, such disorders can involve any combination of motility disturbance, altered mucosal and immune function, dysbiosis of gut microbiota, visceral hypersensitivity, and altered central nervous system processing (5)
Cagrilintide is developed by Novo Nordisk, the same company behind semaglutide (Ozempic/Wegovy) and the CagriSema combination
5-MTHF is then used in another chemical cycle called the methionine cycle , which is important for making proteins, methylation reactions, and regulating blood levels of homocysteine an amino acid linked to cardiovascular disease
A comprehensive review: sphingolipid metabolism and implications of disruption in sphingolipid homeostasis
doi: 10.1007/s00262-024-03867-3 8 LiJZhangHDaiZ
3 TeedeHJTayCTLavenJSEDokrasAMoranLJPiltonenTTet al